NCT04389632 2026-04-20
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
Seagen Inc.
Phase 1 Recruiting
Seagen Inc.
Bristol-Myers Squibb
Daiichi Sankyo
University Health Network, Toronto
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins